Abstract
Purpose
The NOG protein is a secretory antagonist of bone morphogenetic proteins (BMPs). Nog−/− mouse embryos demonstrate proximal esophageal atresia (EA) and distal tracheoesophageal fistula (TEF) compatible with the most common configuration of EA/TEF observed in humans. Four microdeletions that span the NOG locus at 17q22 have been described in human patients having EA/TEF. We investigated the incidence of point mutations in the coding region of the NOG gene in human EA/TEF.
Methods
DNA was collected from 50 patients previously treated for EA/TEF. PCR was used to amplify the coding region of NOG. To detect single nucleotide polymorphisms (SNPs), amplicons were subjected to temperature gradient capillary electrophoresis (TGCE). Candidate SNPs were directly sequenced.
Results
TGCE analysis revealed a SNP in the coding region of NOG in 1 of 50 patients (2%). DNA sequencing revealed a synonymous SNP at position 468 (C–T) of the NOG coding region.
Conclusion
SNPs in the coding region of the NOG gene are identified infrequently in human cases of EA/TEF. Further investigation of SNPs in the promoter region of NOG is warranted, as is the effect of synonymous SNPs on NOG mRNA stability.
Similar content being viewed by others
References
Shaw-Smith C (2006) Oesophageal atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and epidemiology. J Med Genet 43(7):545–554. doi:10.1136/jmg.2005.038158
Holder TM, Ashcraft KW (1966) Esophageal atresia and tracheoesophageal fistula. Curr Probl Surg 3(8):2–68
Berrebi D, Lebras MN, Belarbi N, Couturier J, Fattet S, Faye A, Peuchmaur M, de Lagausie P (2006) Bilateral adrenal neuroblastoma and nephroblastoma occurring synchronously in a child with Fanconi’s anemia and VACTERL syndrome. J Pediatr Surg 41(1):e11–e14. doi:10.1016/j.jpedsurg.2005.10.087
van Bokhoven H, Celli J, van Reeuwijk J, Rinne T, Glaudemans B, van Beusekom E, Rieu P, Newbury-Ecob RA, Chiang C, Brunner HG (2005) MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet 37(5):465–467. doi:10.1038/ng1546
Williamson KA, Hever AM, Rainger J, Rogers RC, Magee A, Fiedler Z, Keng WT, Sharkey FH, McGill N, Hill CJ, Schneider A, Messina M, Turnpenny PD, Fantes JA, van Heyningen V, FitzPatrick DR (2006) Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Hum Mol Genet 15(9):1413–1422. doi:10.1093/hmg/ddl064
Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC, Schoenmakers EF, Brunner HG, Veltman JA, van Kessel AG (2004) Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36(9):955–957. doi:10.1038/ng1407
Ondrey F, Griffith A, Van Waes C, Rudy S, Peters K, McCullagh L, Biesecker LG (2000) Asymptomatic laryngeal malformations are common in patients with Pallister-Hall syndrome. Am J Med Genet 94(1):64–67. doi:10.1002/1096-8628(20000904)94:1<64
De Falco F, Cainarca S, Andolfi G, Ferrentino R, Berti C, Rodriguez Criado G, Rittinger O, Dennis N, Odent S, Rastogi A, Liebelt J, Chitayat D, Winter R, Jawanda H, Ballabio A, Franco B, Meroni G (2003) X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum. Am J Med Genet A 120A(2):222–228. doi:10.1002/ajmg.a.10265
Chittmittrapap S, Spitz L, Kiely EM, Brereton RJ (1989) Oesophageal atresia and associated anomalies. Arch Dis Child 64(3):364–368
Stankiewicz P, Sen P, Bhatt SS, Storer M, Xia Z, Bejjani BA, Ou Z, Wiszniewska J, Driscoll DJ, Maisenbacher MK, Bolivar J, Bauer M, Zackai EH, McDonald-McGinn D, Nowaczyk MM, Murray M, Hustead V, Mascotti K, Schultz R, Hallam L, McRae D, Nicholson AG, Newbury R, Durham-O’Donnell J, Knight G, Kini U, Shaikh TH, Martin V, Tyreman M, Simonic I, Willatt L, Paterson J, Mehta S, Rajan D, Fitzgerald T, Gribble S, Prigmore E, Patel A, Shaffer LG, Carter NP, Cheung SW, Langston C, Shaw-Smith C (2009) Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 84(6):780–791. doi:10.1016/j.ajhg.2009.05.005
Li Y, Litingtung Y, Ten Dijke P, Chiang C (2007) Aberrant Bmp signaling and notochord delamination in the pathogenesis of esophageal atresia. Dev Dyn 236(3):746–754. doi:10.1002/dvdy.21075
Smith WC, Harland RM (1992) Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70(5):829–840. pii: 0092-8674(92)90316-5
Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman FR, Reardon W, Patton M, Francomano CA, Warman ML (1999) Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21(3):302–304. doi:10.1038/6821
Krakow D, Reinker K, Powell B, Cantor R, Priore MA, Garber A, Lachman RS, Rimoin DL, Cohn DH (1998) Localization of a multiple synostoses-syndrome disease gene to chromosome 17q21–22. Am J Hum Genet 63(1):120–124. doi:10.1086/301921
Brunet LJ, McMahon JA, McMahon AP, Harland RM (1998) Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280(5368):1455–1457
Brown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Moroi SE, Milunsky JM, Lesperance MM (2002) Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 71(3):618–624. doi:10.1086/342067
Takahashi T, Takahashi I, Komatsu M, Sawaishi Y, Higashi K, Nishimura G, Saito H, Takada G (2001) Mutations of the NOG gene in individuals with proximal symphalangism and multiple synostosis syndrome. Clin Genet 60(6):447–451. pii: 600607
Khalifa MM, MacLeod PM, Duncan AM (1993) Additional case of de novo interstitial deletion del(17)(q21.3q23) and expansion of the phenotype. Clin Genet 44(5):258–261
Park JP, Moeschler JB, Berg SZ, Bauer RM, Wurster-Hill DH (1992) A unique de novo interstitial deletion del(17)(q21.3q23) in a phenotypically abnormal infant. Clin Genet 41(1):54–56
Dallapiccola B, Mingarelli R, Digilio C, Obregon MG, Giannotti A (1993) Interstitial deletion del(17) (q21.3q23 or 24.2) syndrome. Clin Genet 43(1):54–55
Marsh AJ, Wellesley D, Burge D, Ashton M, Browne C, Dennis NR, Temple K (2000) Interstitial deletion of chromosome 17 (del(17)(q22q23.3)) confirms a link with oesophageal atresia. J Med Genet 37(9):701–704
Levin ML, Shaffer LG, Lewis R, Gresik MV, Lupski JR (1995) Unique de novo interstitial deletion of chromosome 17, del(17) (q23.2q24.3) in a female newborn with multiple congenital anomalies. Am J Med Genet 55(1):30–32. doi:10.1002/ajmg.1320550110
Mickelson EC, Robinson WP, Hrynchak MA, Lewis ME (1997) Novel case of del(17)(q23.1q23.3) further highlights a recognizable phenotype involving deletions of chromosome (17)(q21q24). Am J Med Genet 71(3):275–279. doi:10.1002/(SICI)1096-8628(19970822)71:3<275
Puusepp H, Zilina O, Teek R, Mannik K, Parkel S, Kruustuk K, Kuuse K, Kurg A, Ounap K (2009) 5.9 Mb microdeletion in chromosome band 17q22–q23.2 associated with tracheo-esophageal fistula and conductive hearing loss. Eur J Med Genet 52(1):71–74. doi:10.1016/j.ejmg.2008.09.006
Li Q, Liu Z, Monroe H, Culiat CT (2002) Integrated platform for detection of DNA sequence variants using capillary array electrophoresis. Electrophoresis 23(10):1499–1511. doi:10.1002/1522-2683(200205)23:10<1499
Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C (2009) Silent (synonymous) SNPs: should we care about them? Methods Mol Biol 578:23–39. doi:10.1007/978-1-60327-411-1_2
Potti TA, Petty EM, Lesperance MM (2011) A comprehensive review of reported heritable noggin-associated syndromes and proposed clinical utility of one broadly inclusive diagnostic term: NOG-related-symphalangism spectrum disorder (NOG-SSD). Hum Mutat 32(8):877–886. doi:10.1002/humu.21515
Felix JF, de Jong EM, Torfs CP, de Klein A, Rottier RJ, Tibboel D (2009) Genetic and environmental factors in the etiology of esophageal atresia and/or tracheoesophageal fistula: an overview of the current concepts. Birth Defects Res A Clin Mol Teratol 85(9):747–754. doi:10.1002/bdra.20592
Borovecki F, Jelic M, Grgurevic L, Sampath KT, Bosukonda D, Vukicevic S (2004) Bone morphogenetic protein-7 from serum of pregnant mice is available to the fetus through placental transfer during early stages of development. Nephron Exp Nephrol 97(1):e26–e32. doi:10.1159/000077595
Acknowledgments
This manuscript is dedicated in loving memory of our colleague and co-author, Joshua B. Pietsch (1975–2010), whose tireless efforts, despite a chronic neurodegenerative disease that ultimately claimed his life, made this study possible. The authors would also like to acknowledge Andrew C. Ward for helping with sample preparation and DNA extraction.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murphy, A.J., Li, Y., Pietsch, J.B. et al. Mutational analysis of NOG in esophageal atresia and tracheoesophageal fistula patients. Pediatr Surg Int 28, 335–340 (2012). https://doi.org/10.1007/s00383-011-3022-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-011-3022-1